Mobile

A Randomised, Double-blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects with Moderately-to Severely Active Crohn’s Disease

Update Il y a 4 ans
Reference: EUCTR2010-022382-10

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

• To assess the efficacy of GSK1605786A compared with placebo as an induction therapy in subjects with moderately-to-severely active Crohn’s disease over 12 weeks.

Inclusion criteria

  • Subjects with Moderately-to-Severely Active Crohn’s Disease

Links